Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).

NCT02880878 is registered in ClinicalTrials.gov with Nico Corporation as lead sponsor.

NCT NCT02880878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02880878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).
Lead sponsor
Nico Corporation
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
February 28, 2023
Enrollment
300 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral hemorrhage, intracerebral haemorrhage, intracerebral hemorrhage